TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: cervical spine mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the plasma concentration versus time from time 0 to t (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time 0 to ∞ (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time ≥90% maximal oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Electromyographic activity of lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Electromyographic activity of upper limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Preference for checklist style over thermometer format
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total number of perceived barriers for mental health and rehabilitation services
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Missing data rates between checklist and thermometer formats
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum extravasate enzyme activities (CK, ALT, LDH, AST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective fatigue status
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Reduction in muscle cramps frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of scheduled chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeatable muscle cramps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: need for massive transfusion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean bleeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boezaart score (suitability of operation field)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: collaborative care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: quicker referral paths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interprofessional competencies
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Serum levels of cTnT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum levels of LDH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burke score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean retention values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in 17-iFFI and FAOS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: In-hospital complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Post-training competency in positive pressure ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in MADRS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: prevalence of post-orthodontic WSLs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day surgical wound complications (SWCs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with AF detected over 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consent to quitline referral
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma levels of tumor necrosis factor‐alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutrophils-to-lymphocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: discourse production measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain/Discomfort
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: End-Breathing Temperature (EBT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: emotional ability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Exercise-induced increase in EGP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FACT-HN functional well-being index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PRO-CTCAE scores
Endpoint domain: Adverse events/effects
Primary endpoint: FT placement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: percentage of ischemic myocardium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total anxiety score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative incidence of progression
Endpoint domain: Mortality/survival
Primary endpoint: occurrences of AF per standard deviation change in height
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retention at post-therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduced engulfment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychomotor Skills (PS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dexterity Skills (DS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort Level (CS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: vocational recovery
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: High NF-L plasma levels at 48 hours after cardiac arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: one-and three-year survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Annualized Attack Rate (AAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in daytime ambulatory BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with controlled daytime ambulatory BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prediction accuracy of lipid profile traits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to euthyroidism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients euthyroid at study end
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Duration of sustained normal serum thyrotropin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Intrahepatic Fat (IHF) percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Physician recommendation of Tai Chi
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients attending appointments with good or excellent bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Severity of clinical rectal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Endoscopic findings severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seven-day point prevalence abstinence at 90-day follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of days smoked in the past 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: displacement of femurs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stresses of implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stresses of the general system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GRF LSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impulse LSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LR LSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of STIR signal increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusive breastfeeding rates
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: intramuscular adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: grade 2 to 4 complications
Endpoint domain: Adverse events/effects
Primary endpoint: grade B/C POPF
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative in-hospital stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Presence/absence of relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower-limb Fugl-Meyer improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: whitening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical-site complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of participants achieving pain freedom (PF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants experiencing ≥ 1 CNS-CTEAE
Endpoint domain: Adverse events/effects
Primary endpoint: Patient global impression of change (PGIC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of Stage III/IV periodontitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of progression of periodontitis (≥1 site with ΔCAL ≥3 mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative sIgA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: current/average NRS pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough stress test negative rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri- or postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Anorectal manometry data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wexner anal function scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of visual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative oxygenation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to suspension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: utility of platform rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Regular menstruation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-year progression
Endpoint domain: Mortality/survival
Primary endpoint: FL-related death
Endpoint domain: Mortality/survival
Primary endpoint: Bactericidal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of intravenous meropenem
Endpoint domain: Adverse events/effects
Primary endpoint: OLST improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TMT-B improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Factual memories
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total attempted scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net attempted scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: STAI-s scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient willingness to participate in the CARES trial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of postoperative tumor bed hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: Acute non-hematological toxicities of grade 3 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Median 2 year loco-regional control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in patient-reported outcome measures
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of painful invasive vascular procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Number of X-rays for assessment of correct CL-position
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PHep levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative symptom scores (FLU‐Pro‐Plus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taste/smell improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maintenance capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance of maintenance activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knowledge of wheelchair maintenance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Functional recovery of the upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma levels of gremlin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma levels of MIF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma levels of CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PA nosocomial pneumonia
Endpoint domain: Mortality/survival
Primary endpoint: Health-related quality of life (HRQoL) assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-radiotherapy decline in MMSE scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Grade ≥ 2 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Median percentage reduction in focal seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Clinically meaningful improvements in Patient Weighted Quality of Life in Epilepsy Questionnaire 31 total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: LDAT scores differentiation between accepted/declined groups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of LDAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain on the first three days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interference with oral hygiene
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression to renal combined endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Center-involving DME development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of adapted DBT delivery
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Satisfaction of participants and caregivers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RV-PA coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of PEW (Protein Energy Wasting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: self-reported anxiety scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: eye strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Poor medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PRU level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidences of side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in heart rate and oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VAS values of nausea and emesis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean improvement in exam score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower limb functional scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of delivery with preeclampsia
Endpoint domain: Mortality/survival
Primary endpoint: percent of maximum phonation time goal attained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arm pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver fat content reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean postoperative ketoprofen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced expiratory volume at 1 s (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diffusion capacity of the lung for carbon monoxide divided by the mean alveolar volume (DLCO/Va)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to first hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Composite outcome of all-cause hospitalization or death
Endpoint domain: Mortality/survival
Primary endpoint: Knowledge improvement in nasogastric tube feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with learning model
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive load
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge transfer to orthodontic patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: sRPE and Edwards load relationship
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical scores after 12 months follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amblyopic eye visual acuity (VA) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breech presentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: PGA score of 'clear' or 'almost clear'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in gray matter atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Morphologic remissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal residual disease‐negative remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central line-associated bloodstream infections
Endpoint domain: Adverse events/effects
Primary endpoint: Insertion site pain
Endpoint domain: Adverse events/effects
Primary endpoint: Adequate sedation at 10 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to adequate sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen supplementation
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HKA difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive coping style score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: AIDS knowledge scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AIDS attitude scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to first administration of rescue analgesic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores at different postoperative time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QoR‐15 scores on postoperative days 1 and 3
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life